Cannara Biotech Inc. (TSXV:LOVE)
Canada
· Delayed Price · Currency is CAD 1.690
+0.020 (1.20%)
At close: Dec 5, 2025
Cannara Biotech Balance Sheet
Financials in millions CAD. Fiscal year is September - August.
Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 14.36 | 6.62 | 4.27 | 12.11 | 8.16 | Upgrade
|
| Cash & Short-Term Investments | 14.36 | 6.62 | 4.27 | 12.11 | 8.16 | Upgrade
|
| Cash Growth | 116.91% | 55.02% | -64.75% | 48.48% | 4.99% | Upgrade
|
| Accounts Receivable | 14.11 | 13.04 | 10.59 | 8.62 | 2.92 | Upgrade
|
| Other Receivables | - | - | - | - | 0.05 | Upgrade
|
| Receivables | 14.11 | 13.04 | 10.59 | 8.62 | 2.97 | Upgrade
|
| Inventory | 51.33 | 40.07 | 33.77 | 18.98 | 7.41 | Upgrade
|
| Prepaid Expenses | 2.36 | 2.85 | 3.06 | 1.28 | 0.71 | Upgrade
|
| Other Current Assets | - | 4.9 | - | - | - | Upgrade
|
| Total Current Assets | 82.16 | 67.47 | 51.7 | 40.99 | 19.25 | Upgrade
|
| Property, Plant & Equipment | 86 | 84.94 | 89.44 | 83.4 | 71.75 | Upgrade
|
| Long-Term Accounts Receivable | - | - | - | - | 0.07 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 1.95 | - | - | - | Upgrade
|
| Long-Term Deferred Charges | 0.05 | - | 0.06 | - | - | Upgrade
|
| Other Long-Term Assets | 0.44 | 0.36 | 0.33 | 1.22 | 0.95 | Upgrade
|
| Total Assets | 168.65 | 154.72 | 141.52 | 125.62 | 92.02 | Upgrade
|
| Accounts Payable | 11 | 9.42 | 8.12 | 8.85 | 6.19 | Upgrade
|
| Accrued Expenses | 9.77 | 7.94 | 6.86 | 0.77 | 0.07 | Upgrade
|
| Short-Term Debt | 6.76 | 6.26 | 3 | - | - | Upgrade
|
| Current Portion of Long-Term Debt | 6.26 | 2.97 | 2.97 | 1.97 | 0.3 | Upgrade
|
| Current Portion of Leases | 0.28 | 0.28 | 0.08 | 0.22 | 0.23 | Upgrade
|
| Current Unearned Revenue | 0.13 | 0.13 | 0.16 | 0.05 | 0.04 | Upgrade
|
| Total Current Liabilities | 34.2 | 27 | 21.18 | 11.86 | 6.83 | Upgrade
|
| Long-Term Debt | 28.17 | 38.45 | 39.64 | 46.19 | 20.15 | Upgrade
|
| Long-Term Leases | 0.11 | 0.37 | 0.1 | 0.02 | 0.22 | Upgrade
|
| Long-Term Unearned Revenue | 0.88 | 0.94 | 0.86 | 0.82 | 0.71 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 3.07 | - | - | - | - | Upgrade
|
| Total Liabilities | 66.43 | 66.77 | 61.78 | 58.88 | 27.91 | Upgrade
|
| Common Stock | 89.76 | 88.52 | 88.8 | 83.3 | 83.21 | Upgrade
|
| Additional Paid-In Capital | 12.28 | 12.33 | 10.35 | 9.72 | 9.41 | Upgrade
|
| Retained Earnings | 0.18 | -12.9 | -19.34 | -26.3 | -28.61 | Upgrade
|
| Comprehensive Income & Other | - | - | -0.07 | 0.02 | 0.1 | Upgrade
|
| Total Common Equity | 102.22 | 87.95 | 79.74 | 66.74 | 64.12 | Upgrade
|
| Shareholders' Equity | 102.22 | 87.95 | 79.74 | 66.74 | 64.12 | Upgrade
|
| Total Liabilities & Equity | 168.65 | 154.72 | 141.52 | 125.62 | 92.02 | Upgrade
|
| Total Debt | 41.58 | 48.33 | 45.78 | 48.39 | 20.9 | Upgrade
|
| Net Cash (Debt) | -27.22 | -41.71 | -41.51 | -36.28 | -12.74 | Upgrade
|
| Net Cash Per Share | -0.29 | -0.46 | -0.46 | -0.41 | -0.17 | Upgrade
|
| Filing Date Shares Outstanding | 94.9 | 90.02 | 90.02 | 87.7 | 87.65 | Upgrade
|
| Total Common Shares Outstanding | 91.43 | 90.02 | 90.31 | 87.7 | 87.65 | Upgrade
|
| Working Capital | 47.96 | 40.47 | 30.51 | 29.13 | 12.41 | Upgrade
|
| Book Value Per Share | 1.12 | 0.98 | 0.88 | 0.76 | 0.73 | Upgrade
|
| Tangible Book Value | 102.22 | 87.95 | 79.74 | 66.74 | 64.12 | Upgrade
|
| Tangible Book Value Per Share | 1.12 | 0.98 | 0.88 | 0.76 | 0.73 | Upgrade
|
| Land | 2.33 | 2.33 | 2.45 | 2.45 | 2.45 | Upgrade
|
| Buildings | 77.76 | 76.71 | 75.48 | 64.3 | 44.79 | Upgrade
|
| Machinery | 25.49 | 20.65 | 18.57 | 14.22 | 8.47 | Upgrade
|
| Construction In Progress | 4.65 | 4.71 | 6.73 | 11.53 | 21.23 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.